Camurus AB
CAMX
ISIN SE0007692850 / Valor 30510553
Camurus AB
UMushroom community rating:
About company
Camurus AB is a Swedish pharmaceutical company focused on developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic diseases. The company's proprietary FluidCrystal® drug delivery technologies and extensive R&D expertise are utilized to create new medicinal products with best-in-class potential. Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer, and endocrine diseases, which are developed both in-house and in collaboration with international pharmaceutical companies. With headquarters in Lund, Sweden, and regional offices in Cambridge, UK, Mainz, Germany, and Sydney, Australia, Camurus has nearly 200 employees and is listed on Nasdaq Stockholm under the ticker "CAMX."
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
3318 M
Market cap (USD)
86,735
Daily traded volume (Shares)
581.5 / 567
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
